Skip to content
BLACK BOOK
manufacturer✓ Verified☎ Contact on file

Biogen Inc.

Biological Products, (No Diagnostic Substances) · Cambridge, MA, United States

  1. PrincipalsChristopher ViehbacherPresident and CEOMichel VounatsosChief Executive OfficerRobin KramerChief Financial Officerand 8 more
  2. CompanyBiogen Inc.Cambridge, MA, United States
  3. Phone line+1 (617) 679-2000General business

Biogen Inc. is an SEC-registered Nasdaq-listed company (ticker BIIB) classified under SIC 2836: Biological Products, (No Diagnostic Substances).

Capabilities

✓ Pharmaceutical manufacturing
Evidence for each capability
  • Pharmaceutical manufacturing. SIC 2836 — Biological Products, (No Diagnostic Substances) — SEC EDGAR company submissions

People 11

Chief executive

Christopher ViehbacherPresident and CEO
Michel VounatsosChief Executive OfficerPast role

Finance

Robin KramerChief Financial Officer
Sean GodboutChief Accounting Officer

Technology & engineering

Jane GroganHead of Research
Rachid IzzarHead of Global Product Strat.

Legal

Susan H AlexanderEVP Chief Legal Officer
Everyone else on file (4)
Ginger GregoryEVP, Human Resources
Adam KeeneyHead of Corporate Development
Nicole MurphyHead of Pharm Ops and Tech
Priya SinghalHead of Development

Supplier profile

Production
Yes

Source timeline

  1. Record created from SEC EDGAR company submissions

    SEC EDGAR company submissions ↗
  2. Christopher Viehbacher — President and CEO

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  3. Robin Kramer — Chief Financial Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  4. Sean Godbout — Chief Accounting Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  5. Michel Vounatsos — Chief Executive Officer

    Wikidata ↗

Similar makers